The deal is expected to close in the first quarter of 2023, LG Chem said.
(Reporting by Joyce Lee; Editing by Kirsten Donovan)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
373,500 KRW | +0.13% | -1.32% | -25.15% |
Apr. 24 | South Korean shares gain 2% as chip, battery stocks rally | RE |
Apr. 24 | LG Chem denies report it will merge naphtha business with Lotte Chemical | RE |
SEOUL (Reuters) - South Korea's LG Chem Ltd said in a regulatory filing on Tuesday that it is investing $566 million to acquire U.S. firm Aveo Pharmaceuticals Inc and enter the U.S. anti-cancer drug market.
The deal is expected to close in the first quarter of 2023, LG Chem said.
(Reporting by Joyce Lee; Editing by Kirsten Donovan)
1st Jan change | Capi. | |
---|---|---|
-25.15% | 20.62B | |
+4.61% | 39.69B | |
-14.52% | 13.26B | |
-13.48% | 9.69B | |
-8.75% | 9.66B | |
-4.50% | 6.56B | |
+3.01% | 6.12B | |
-30.31% | 5.28B | |
-14.67% | 3.47B | |
-34.73% | 3.08B |